Vera Therapeutics, Inc. (VERA)
Vera Therapeutics Market Cap : 2.936B for April 2, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Cogent Biosciences, Inc. | 5.708B |
| Syndax Pharmaceuticals, Inc. | 2.336B |
| Johnson & Johnson | 582.73B |
| Eli Lilly & Co. | 819.44B |
| United Therapeutics Corp. | 24.50B |
Market Cap Related Metrics
| PEG Ratio | -0.1258 |
| Price to Book Value | 4.856 |
| Price | 40.86 |
| Earnings Yield | -11.34% |
| PEGY Ratio | -0.1258 |